1. Considered and approved and taken on records the Standalone and Consolidated Audited Financial Results along with the Statement of Assets and Liabilities and the Audit Report for the ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Shivam Chemicals Limited approved the Standalone and Consolidated Audited Financial Results for the half-year and full year ended 31st March 2025 at their meeting held on 30th May 2025. Consolidated revenue from operations grew sharply to ₹22,413.34 lakhs from ₹14,654.11 lakhs in FY24, a jump of about 53%. Consolidated Profit After Tax rose to ₹209.30 lakhs from ₹120.65 lakhs, up roughly 73%, while standalone PAT grew to ₹257.14 lakhs from ₹200.64 lakhs (~28%). The statutory auditors M/s PSRD & Co. issued an unmodified (clean) opinion on the financial statements. The company remains listed on the SME platform of BSE (scrip ID: 544165) since April 2024, with no investor complaints pending.
Strong top-line and bottom-line growth for a newly-listed SME company is positive for shareholders, signalling healthy business expansion. However, cash flow from operations turned sharply negative on a consolidated basis (₹1,461 lakhs outflow vs ₹494 lakhs inflow last year) due to a big rise in receivables and inventories, which investors should monitor closely.